{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:41:06Z","timestamp":1790458866423,"version":"4.1.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00059-019-4786-7","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T07:04:11Z","timestamp":1549955051000},"page":"138-146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Inflammation in thoracic aortic aneurysms","Entz\u00fcndungsprozesse bei thorakalen Aortenaneurysmen"],"prefix":"10.1007","volume":"44","author":[{"given":"N. E. H.","family":"Dinesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. P.","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"key":"4786_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cjca.2015.11.007","volume":"32","author":"TJ Bradley","year":"2016","unstructured":"Bradley TJ, Bowdin SC, Morel CF et\u00a0al (2016) The expanding clinical spectrum of extracardiovascular and cardiovascular manifestations of heritable thoracic aortic aneurysm and dissection. Can J Cardiol 32:86\u201399. https:\/\/doi.org\/10.1016\/j.cjca.2015.11.007","journal-title":"Can J Cardiol"},{"key":"4786_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-med-100415-022956","volume":"68","author":"DM Milewicz","year":"2017","unstructured":"Milewicz DM, Prakash SK, Ramirez F (2017) Therapeutics targeting drivers of thoracic aortic aneurysms and acute aortic dissections: Insights from predisposing genes and mouse models. Annu Rev Med 68:51\u201367. https:\/\/doi.org\/10.1146\/annurev-med-100415-022956","journal-title":"Annu Rev Med"},{"key":"4786_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/352337a0","volume":"352","author":"HC Dietz","year":"1991","unstructured":"Dietz HC, Cutting GR, Pyeritz RE et\u00a0al (1991) Marfan syndrome caused by a\u00a0recurrent de novo missense mutation in the fibrillin gene. Nature 352:337\u2013339","journal-title":"Nature"},{"key":"4786_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/humu.10249","volume":"22","author":"G Collod-Beroud","year":"2003","unstructured":"Collod-Beroud G, Le Bourdelles S, Ades L et al (2003) Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Hum Mutat 22:199\u2013208","journal-title":"Hum Mutat"},{"key":"4786_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ajhg.2014.10.018","volume":"95","author":"M Barbier","year":"2014","unstructured":"Barbier M, Gross MS, Aubart M et al (2014) MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. Am J Hum Genet 95:736\u2013743. https:\/\/doi.org\/10.1016\/j.ajhg.2014.10.018","journal-title":"Am J Hum Genet"},{"key":"4786_CR6","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/CIRCRESAHA.115.307130","volume":"118","author":"DC Guo","year":"2016","unstructured":"Guo DC, Regalado ES, Gong L et\u00a0al (2016) LOX mutations predispose to thoracic aortic aneurysms and dissections. Circ Res 118:928\u2013934. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307130","journal-title":"Circ Res"},{"key":"4786_CR7","doi-asserted-by":"publisher","first-page":"8759","DOI":"10.1073\/pnas.1601442113","volume":"113","author":"VS Lee","year":"2016","unstructured":"Lee VS, Halabi CM, Hoffman EP et\u00a0al (2016) Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans. Proc Natl Acad Sci USA 113:8759\u20138764. https:\/\/doi.org\/10.1073\/pnas.1601442113","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"4786_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1086\/504304","volume":"78","author":"V Hucthagowder","year":"2006","unstructured":"Hucthagowder V, Sausgruber N, Kim KH et al (2006) Fibulin-4: A\u00a0novel gene for an autosomal recessive cutis laxa syndrome. Am J Hum Genet 78:1075\u20131080","journal-title":"Am J Hum Genet"},{"key":"4786_CR9","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/ajmg.a.31980","volume":"143A","author":"M Dasouki","year":"2007","unstructured":"Dasouki M, Markova D, Garola R et al (2007) Compound heterozygous mutations in fibulin-4 causing neonatal lethal pulmonary artery occlusion, aortic aneurysm, arachnodactyly, and mild cutis laxa. Am J Med Genet\u00a0A 143A:2635\u20132641","journal-title":"Am J Med Genet A"},{"key":"4786_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/humu.22920","volume":"37","author":"A Capuano","year":"2016","unstructured":"Capuano A, Bucciotti F, Farwell KD et al (2016) Diagnostic exome sequencing identifies a\u00a0novel gene, EMILIN1, associated with autosomal-dominant hereditary connective tissue disease. Hum Mutat 37:84\u201397. https:\/\/doi.org\/10.1002\/humu.22920","journal-title":"Hum Mutat"},{"key":"4786_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/ng.2348","volume":"44","author":"C Boileau","year":"2012","unstructured":"Boileau C, Guo DC, Hanna N et\u00a0al (2012) TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet 44:916\u2013921. https:\/\/doi.org\/10.1038\/ng.2348","journal-title":"Nat Genet"},{"key":"4786_CR12","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2015.01.040","volume":"65","author":"AM Bertoli-Avella","year":"2015","unstructured":"Bertoli-Avella AM, Gillis E, Morisaki H et al (2015) Mutations in a\u00a0TGF-beta ligand, TGFB3, cause syndromic aortic aneurysms and dissections. J\u00a0Am Coll Cardiol 65:1324\u20131336. https:\/\/doi.org\/10.1016\/j.jacc.2015.01.040","journal-title":"J Am Coll Cardiol"},{"key":"4786_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2005","unstructured":"Loeys BL, Chen J, Neptune ER et\u00a0al (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275\u2013281","journal-title":"Nat Genet"},{"key":"4786_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ng.744","volume":"43","author":"IM Laar Van De","year":"2011","unstructured":"Van De Laar IM, Oldenburg RA, Pals G et al (2011) Mutations in SMAD3 cause a\u00a0syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43:121\u2013126. https:\/\/doi.org\/10.1038\/ng.744","journal-title":"Nat Genet"},{"key":"4786_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ajmg.a.35659","volume":"161A","author":"P Teekakirikul","year":"2013","unstructured":"Teekakirikul P, Milewicz DM, Miller DT et\u00a0al (2013) Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations. Am J Med Genet\u00a0A 161A:185\u2013191. https:\/\/doi.org\/10.1002\/ajmg.a.35659","journal-title":"Am J Med Genet A"},{"key":"4786_CR16","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ng.2421","volume":"44","author":"AJ Doyle","year":"2012","unstructured":"Doyle AJ, Doyle JJ, Bessling SL et al (2012) Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet 44:1249\u20131254. https:\/\/doi.org\/10.1038\/ng.2421","journal-title":"Nat Genet"},{"key":"4786_CR17","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/ng.2007.6","volume":"39","author":"DC Guo","year":"2007","unstructured":"Guo DC, Pannu H, Tran-Fadulu V et al (2007) Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 39:1488\u20131493","journal-title":"Nat Genet"},{"key":"4786_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ajhg.2010.10.006","volume":"87","author":"L Wang","year":"2010","unstructured":"Wang L, Guo DC, Cao J et\u00a0al (2010) Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet 87:701\u2013707. https:\/\/doi.org\/10.1016\/j.ajhg.2010.10.006","journal-title":"Am J Hum Genet"},{"key":"4786_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ajhg.2013.06.019","volume":"93","author":"DC Guo","year":"2013","unstructured":"Guo DC, Regalado E, Casteel DE et al (2013) Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am J Hum Genet 93:398\u2013404. https:\/\/doi.org\/10.1016\/j.ajhg.2013.06.019","journal-title":"Am J Hum Genet"},{"key":"4786_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/cvr\/cvy006","volume":"114","author":"JB Michel","year":"2018","unstructured":"Michel JB, Jondeau G, Milewicz DM (2018) From genetics to response to injury: Vascular smooth muscle cells in aneurysms and dissections of the ascending aorta. Cardiovasc Res 114:578\u2013589. https:\/\/doi.org\/10.1093\/cvr\/cvy006","journal-title":"Cardiovasc Res"},{"key":"4786_CR21","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","volume":"366","author":"DP Judge","year":"2005","unstructured":"Judge DP, Dietz HC (2005) Marfan\u2019s syndrome. Lancet 366:1965\u20131976","journal-title":"Lancet"},{"key":"4786_CR22","doi-asserted-by":"publisher","first-page":"e266","DOI":"10.1161\/CIR.0b013e3181d4739e","volume":"121","author":"LF Hiratzka","year":"2010","unstructured":"Hiratzka LF, Bakris GL, Beckman JA et\u00a0al (2010) 2010 ACCF\/AHA\/AATS\/ACR\/ASA\/SCA\/SCAI\/SIR\/STS\/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: A\u00a0report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121:e266\u2013e369. https:\/\/doi.org\/10.1161\/CIR.0b013e3181d4739e","journal-title":"Circulation"},{"key":"4786_CR23","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"R Erbel","year":"2014","unstructured":"Erbel R, Aboyans V, Boileau C et\u00a0al (2014) 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur Heart\u00a0J 35:2873\u20132926. https:\/\/doi.org\/10.1093\/eurheartj\/ehu281","journal-title":"Eur Heart J"},{"key":"4786_CR24","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","volume":"330","author":"J Shores","year":"1994","unstructured":"Shores J, Berger KR, Murphy EA et al (1994) Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan\u2019s syndrome. N\u00a0Engl J Med 330:1335\u20131341","journal-title":"N Engl J Med"},{"key":"4786_CR25","doi-asserted-by":"publisher","first-page":"CD011103","DOI":"10.1002\/14651858.CD011103.pub2","volume":"11","author":"HK Koo","year":"2017","unstructured":"Koo HK, Lawrence KA, Musini VM (2017) Beta-blockers for preventing aortic dissection in Marfan syndrome. Cochrane Database Syst Rev 11:CD11103. https:\/\/doi.org\/10.1002\/14651858.CD011103.pub2","journal-title":"Cochrane Database Syst. Rev."},{"key":"4786_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.pcad.2018.07.020","volume":"61","author":"E Rurali","year":"2018","unstructured":"Rurali E, Perrucci GL, Pilato CA et\u00a0al (2018) Precise therapy for thoracic aortic aneurysm in Marfan syndrome: A\u00a0puzzle nearing its solution. Prog Cardiovasc Dis 61:328\u2013335. https:\/\/doi.org\/10.1016\/j.pcad.2018.07.020","journal-title":"Prog Cardiovasc Dis"},{"key":"4786_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/MOP.0000000000000671","volume":"30","author":"ME Lindsay","year":"2018","unstructured":"Lindsay ME (2018) Medical management of aortic disease in children with Marfan syndrome. Curr Opin Pediatr 30:639\u2013644. https:\/\/doi.org\/10.1097\/MOP.0000000000000671","journal-title":"Curr Opin Pediatr"},{"key":"4786_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ng1721","volume":"38","author":"L Zhu","year":"2006","unstructured":"Zhu L, Vranckx R, Khau Van Kien P et\u00a0al (2006) Mutations in myosin heavy chain 11 cause a\u00a0syndrome associating thoracic aortic aneurysm\/aortic dissection and patent ductus arteriosus. Nat Genet 38:343\u2013349","journal-title":"Nat Genet"},{"key":"4786_CR29","doi-asserted-by":"publisher","first-page":"7596","DOI":"10.1074\/jbc.M112.427112","volume":"288","author":"N Gao","year":"2013","unstructured":"Gao N, Huang J, He W et\u00a0al (2013) Signaling through myosin light chain kinase in smooth muscles. J\u00a0Biol Chem 288:7596\u20137605. https:\/\/doi.org\/10.1074\/jbc.M112.427112","journal-title":"J Biol Chem"},{"key":"4786_CR30","doi-asserted-by":"publisher","first-page":"e4168","DOI":"10.1073\/pnas.1507587112","volume":"112","author":"H Lu","year":"2015","unstructured":"Lu H, Fagnant PM, Bookwalter CS et al (2015) Vascular disease-causing mutation R258C in ACTA2 disrupts actin dynamics and interaction with myosin. Proc Natl Acad Sci USA 112:e4168\u2013e4177. https:\/\/doi.org\/10.1073\/pnas.1507587112","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"4786_CR31","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/CIRCRESAHA.114.304936","volume":"116","author":"JD Humphrey","year":"2015","unstructured":"Humphrey JD, Schwartz MA, Tellides G et\u00a0al (2015) Role of mechanotransduction in vascular biology: Focus on thoracic aortic aneurysms and dissections. Circ Res 116:1448\u20131461","journal-title":"Circ Res"},{"key":"4786_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nrm3896","volume":"15","author":"JD Humphrey","year":"2014","unstructured":"Humphrey JD, Dufresne ER, Schwartz MA (2014) Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol 15:802\u2013812. https:\/\/doi.org\/10.1038\/nrm3896","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4786_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune ER, Frischmeyer PA, Arking DE et al (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407\u2013411","journal-title":"Nat Genet"},{"key":"4786_CR34","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/circimaging.109.933093","volume":"3","author":"EL Kaijzel","year":"2010","unstructured":"Kaijzel EL, Van Heijningen PM, Wielopolski PA et al (2010) Multimodality imaging reveals a\u00a0gradual increase in matrix metalloproteinase activity at aneurysmal lesions in live fibulin-4 mice. Circ Cardiovasc Imaging 3:567\u2013577. https:\/\/doi.org\/10.1161\/circimaging.109.933093","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"4786_CR35","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ejhg.2010.45","volume":"18","author":"M Renard","year":"2010","unstructured":"Renard M, Holm T, Veith R et al (2010) Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency. Eur J Hum Genet 18:895\u2013901. https:\/\/doi.org\/10.1038\/ejhg.2010.45","journal-title":"Eur J Hum Genet"},{"key":"4786_CR36","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.jbiomech.2015.11.059","volume":"49","author":"C Bellini","year":"2016","unstructured":"Bellini C, Korneva A, Zilberberg L et\u00a0al (2016) Differential ascending and descending aortic mechanics parallel aneurysmal propensity in a\u00a0mouse model of Marfan syndrome. J\u00a0Biomech 49:2383\u20132389. https:\/\/doi.org\/10.1016\/j.jbiomech.2015.11.059","journal-title":"J Biomech"},{"key":"4786_CR37","doi-asserted-by":"publisher","first-page":"e23411","DOI":"10.1371\/journal.pone.0023411","volume":"6","author":"E Moltzer","year":"2011","unstructured":"Moltzer E, Te Riet L, Swagemakers SM et al (2011) Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: Effect of angiotensin II type 1 (AT1) receptor blockade. PLoS ONE 6:e23411. https:\/\/doi.org\/10.1371\/journal.pone.0023411","journal-title":"PLoS ONE"},{"key":"4786_CR38","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1161\/CIRCRESAHA.117.310563","volume":"120","author":"J Chen","year":"2017","unstructured":"Chen J, Peters A, Papke CL et al (2017) Loss of smooth muscle alpha-actin leads to NF-kappaB-dependent increased sensitivity to angiotensin II in smooth muscle cells and aortic enlargement. Circ Res 120:1903\u20131915. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310563","journal-title":"Circ Res"},{"key":"4786_CR39","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1074\/jbc.M806962200","volume":"284","author":"L Carta","year":"2009","unstructured":"Carta L, Smaldone S, Zilberberg L et al (2009) p38 MAPK is an early determinant of promiscuous Smad2\/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J\u00a0Biol Chem 284:5630\u20135636. https:\/\/doi.org\/10.1074\/jbc.M806962200","journal-title":"J Biol Chem"},{"key":"4786_CR40","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/ATVBAHA.114.304412","volume":"35","author":"E Crosas-Molist","year":"2015","unstructured":"Crosas-Molist E, Meirelles T, Lopez-Luque J et al (2015) Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome. Arterioscler Thromb Vasc Biol 35:960\u2013972. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304412","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4786_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.vph.2009.10.005","volume":"52","author":"HH Yang","year":"2010","unstructured":"Yang HH, Van Breemen C, Chung AW (2010) Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress. Vascul Pharmacol 52:37\u201345. https:\/\/doi.org\/10.1016\/j.vph.2009.10.005","journal-title":"Vascul. Pharmacol."},{"key":"4786_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature10152","volume":"474","author":"M Shi","year":"2011","unstructured":"Shi M, Zhu J, Wang R et al (2011) Latent TGF-beta structure and activation. Nature 474:343\u2013349","journal-title":"Nature"},{"key":"4786_CR43","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1083\/jcb.200704042","volume":"179","author":"PJ Wipff","year":"2007","unstructured":"Wipff PJ, Rifkin DB, Meister JJ et al (2007) Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J\u00a0Cell Biol 179:1311\u20131323","journal-title":"J Cell Biol"},{"key":"4786_CR44","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1172\/jci71059","volume":"124","author":"JR Cook","year":"2014","unstructured":"Cook JR, Carta L, Benard L et\u00a0al (2014) Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome 168. J\u00a0Clin Invest 124:1329\u20131339. https:\/\/doi.org\/10.1172\/jci71059","journal-title":"J Clin Invest"},{"key":"4786_CR45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B et al (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3:349\u2013363","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4786_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.128820","volume":"191","author":"DY Leung","year":"1976","unstructured":"Leung DY, Glagov S, Mathews MB (1976) Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 191:475\u2013477","journal-title":"Science"},{"key":"4786_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi JP, Judge DP, Holm TM et\u00a0al (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a\u00a0mouse model of Marfan syndrome. Science 312:117\u2013121","journal-title":"Science"},{"key":"4786_CR48","first-page":"II331","volume":"98","author":"AM Segura","year":"1998","unstructured":"Segura AM, Luna RE, Horiba K et\u00a0al (1998) Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan\u2019s syndrome. Circulation 98:II331\u2013II337","journal-title":"Circulation"},{"key":"4786_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/01.RES.88.1.37","volume":"88","author":"TE Bunton","year":"2001","unstructured":"Bunton TE, Biery NJ, Myers L et\u00a0al (2001) Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a\u00a0mouse model of Marfan syndrome. Circ Res 88:37\u201343","journal-title":"Circ Res"},{"key":"4786_CR50","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/ATVBAHA.114.305150","volume":"35","author":"JR Cook","year":"2015","unstructured":"Cook JR, Clayton NP, Carta L et al (2015) Dimorphic effects of transforming growth factor-beta signaling during aortic aneurysm progression in mice suggest a\u00a0combinatorial therapy for Marfan syndrome. Arterioscler Thromb Vasc Biol 35:911\u2013917","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4786_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/cr.2008.326","volume":"19","author":"MJ Goumans","year":"2009","unstructured":"Goumans MJ, Liu Z, Ten DP (2009) TGF-beta signaling in vascular biology and dysfunction. Cell Res 19:116\u2013127","journal-title":"Cell Res"},{"key":"4786_CR52","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1172\/JCI117251","volume":"93","author":"S Kagami","year":"1994","unstructured":"Kagami S, Border WA, Miller DE et al (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J\u00a0Clin Invest 93:2431\u20132437","journal-title":"J Clin Invest"},{"key":"4786_CR53","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1006\/jmcc.1998.0721","volume":"30","author":"Y Sun","year":"1998","unstructured":"Sun Y, Zhang JQ, Zhang J et al (1998) Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. J\u00a0Mol Cell Cardiol 30:1559\u20131569","journal-title":"J Mol Cell Cardiol"},{"key":"4786_CR54","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1161\/01.ATV.0000225777.58488.f2","volume":"26","author":"M Wang","year":"2006","unstructured":"Wang M, Zhao D, Spinetti G et al (2006) Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall. Arterioscler Thromb Vasc Biol 26:1503\u20131509","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4786_CR55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q Yu","year":"2000","unstructured":"Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163\u2013176","journal-title":"Genes Dev"},{"key":"4786_CR56","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1002\/jcp.24094","volume":"227","author":"L Zilberberg","year":"2012","unstructured":"Zilberberg L, Todorovic V, Dabovic B et al (2012) Specificity of latent TGF-beta binding protein (LTBP) incorporation into matrix: Role of fibrillins and fibronectin. J\u00a0Cell Physiol 227:3828\u20133836","journal-title":"J Cell Physiol"},{"key":"4786_CR57","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0002-9440(10)61229-1","volume":"167","author":"M Wang","year":"2005","unstructured":"Wang M, Zhang J, Spinetti G et al (2005) Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am J Pathol 167:1429\u20131442","journal-title":"Am J Pathol"},{"key":"4786_CR58","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1161\/CIRCULATIONAHA.108.843581","volume":"120","author":"JM Ruddy","year":"2009","unstructured":"Ruddy JM, Jones JA, Stroud RE et\u00a0al (2009) Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta. Circulation 120:S262\u2013S268. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.843581","journal-title":"Circulation"},{"key":"4786_CR59","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1172\/JCI115881","volume":"90","author":"GH Gibbons","year":"1992","unstructured":"Gibbons GH, Pratt RE, Dzau VJ (1992) Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J\u00a0Clin Invest 90:456\u2013461","journal-title":"J Clin Invest"},{"key":"4786_CR60","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jss.2012.12.012","volume":"183","author":"A Nagasawa","year":"2013","unstructured":"Nagasawa A, Yoshimura K, Suzuki R et al (2013) Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms. J\u00a0Surg Res 183:472\u2013477. https:\/\/doi.org\/10.1016\/j.jss.2012.12.012","journal-title":"J Surg Res"},{"key":"4786_CR61","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.1192149","volume":"332","author":"TM Holm","year":"2011","unstructured":"Holm TM, Habashi JP, Doyle JJ et\u00a0al (2011) Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332:358\u2013361. https:\/\/doi.org\/10.1126\/science.1192149","journal-title":"Science"},{"key":"4786_CR62","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1126\/science.1192152","volume":"332","author":"JP Habashi","year":"2011","unstructured":"Habashi JP, Doyle JJ, Holm TM et\u00a0al (2011) Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332:361\u2013365. https:\/\/doi.org\/10.1126\/science.1192152","journal-title":"Science"},{"key":"4786_CR63","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1097\/01.hjh.0000182521.44440.c5","volume":"23","author":"P Lavoie","year":"2005","unstructured":"Lavoie P, Robitaille G, Agharazii M et al (2005) Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J\u00a0Hypertens 23:1895\u20131903","journal-title":"J Hypertens"},{"key":"4786_CR64","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","volume":"103","author":"DS Lim","year":"2001","unstructured":"Lim DS, Lutucuta S, Bachireddy P et\u00a0al (2001) Angiotensin II blockade reverses myocardial fibrosis in a\u00a0transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 103:789\u2013791","journal-title":"Circulation"},{"key":"4786_CR65","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1007\/s10439-016-1616-4","volume":"44","author":"JJ Lee","year":"2016","unstructured":"Lee JJ, Galatioto J, Rao S et\u00a0al (2016) Losartan attenuates degradation of aorta and lung tissue micromechanics in a\u00a0mouse model of severe Marfan syndrome. Ann Biomed Eng 44:2994\u20133006. https:\/\/doi.org\/10.1007\/s10439-016-1616-4","journal-title":"Ann Biomed Eng"},{"key":"4786_CR66","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","volume":"358","author":"BS Brooke","year":"2008","unstructured":"Brooke BS, Habashi JP, Judge DP et al (2008) Angiotensin II blockade and aortic-root dilation in Marfan\u2019s syndrome. N\u00a0Engl J Med 358:2787\u20132795. https:\/\/doi.org\/10.1056\/NEJMoa0706585","journal-title":"N Engl J Med"},{"key":"4786_CR67","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cjca.2015.11.003","volume":"32","author":"MN Singh","year":"2016","unstructured":"Singh MN, Lacro RV (2016) Recent clinical drug trials evidence in Marfan syndrome and clinical implications. Can J Cardiol 32:66\u201377. https:\/\/doi.org\/10.1016\/j.cjca.2015.11.003","journal-title":"Can J Cardiol"},{"key":"4786_CR68","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","volume":"34","author":"M Groenink","year":"2013","unstructured":"Groenink M, Den Hartog AW, Franken R et\u00a0al (2013) Losartan reduces aortic dilatation rate in adults with Marfan syndrome: A\u00a0randomized controlled trial. Eur Heart\u00a0J 34:3491\u20133500. https:\/\/doi.org\/10.1093\/eurheartj\/eht334","journal-title":"Eur Heart J"},{"key":"4786_CR69","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","volume":"8","author":"R Franken","year":"2015","unstructured":"Franken R, Den Hartog AW, Radonic T et\u00a0al (2015) Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome. Circ Cardiovasc Genet 8:383\u2013388. https:\/\/doi.org\/10.1161\/CIRCGENETICS.114.000950","journal-title":"Circ Cardiovasc Genet"},{"key":"4786_CR70","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","volume":"36","author":"O Milleron","year":"2015","unstructured":"Milleron O, Arnoult F, Ropers J et al (2015) Marfan Sartan: A\u00a0randomized, double-blind, placebo-controlled trial. Eur Heart\u00a0J 36:2160\u20132166. https:\/\/doi.org\/10.1093\/eurheartj\/ehv151","journal-title":"Eur Heart J"},{"key":"4786_CR71","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1161\/ATVBAHA.116.303229","volume":"37","author":"DM Milewicz","year":"2017","unstructured":"Milewicz DM, Trybus KM, Guo DC et\u00a0al (2017) Altered smooth muscle cell force generation as a\u00a0driver of thoracic aortic aneurysms and dissections. Arterioscler Thromb Vasc Biol 37:26\u201334. https:\/\/doi.org\/10.1161\/ATVBAHA.116.303229","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4786_CR72","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ajpath.2017.11.006","volume":"188","author":"SL Sellers","year":"2018","unstructured":"Sellers SL, Milad N, Chan R et al (2018) Inhibition of Marfan syndrome aortic root dilation by losartan: Role of angiotensin II receptor type 1\u2011independent activation of endothelial function. Am J Pathol 188:574\u2013585. https:\/\/doi.org\/10.1016\/j.ajpath.2017.11.006","journal-title":"Am J Pathol"},{"key":"4786_CR73","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nm.4266","volume":"23","author":"J Oller","year":"2017","unstructured":"Oller J, Mendez-Barbero N, Ruiz EJ et al (2017) Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a\u00a0mouse model of Marfan syndrome. Nat Med 23:200\u2013212","journal-title":"Nat Med"},{"key":"4786_CR74","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","volume":"96","author":"L Pereira","year":"1999","unstructured":"Pereira L, Lee SY, Gayraud B et al (1999) Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA 96:3819\u20133823","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"4786_CR75","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1172\/JCI200420641","volume":"114","author":"DP Judge","year":"2004","unstructured":"Judge DP, Biery NJ, Keene DR et\u00a0al (2004) Evidence for a\u00a0critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J\u00a0Clin Invest 114:172\u2013181","journal-title":"J Clin Invest"},{"key":"4786_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carpath.2018.10.002","volume":"38","author":"S Hibender","year":"2019","unstructured":"Hibender S, Wanga S, Van Der Made I et\u00a0al (2019) Renal cystic disease in the Fbn1C1039G\/+ Marfan mouse is associated with enhanced aortic aneurysm formation. Cardiovasc Pathol 38:1\u20136","journal-title":"Cardiovasc Pathol"},{"key":"4786_CR77","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1161\/CIRCULATIONAHA.105.601674","volume":"114","author":"G Guo","year":"2006","unstructured":"Guo G, Booms P, Halushka M et al (2006) Induction of macrophage chemotaxis by aortic extracts of the mgR Marfan mouse model and a\u00a0GxxPG-containing fibrillin-1 fragment. Circulation 114:1855\u20131862","journal-title":"Circulation"},{"key":"4786_CR78","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1161\/circresaha.108.174367","volume":"102","author":"AWY Chung","year":"2008","unstructured":"Chung AWY, Yang HHC, Radomski MW et al (2008) Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 102:e73\u2013e85. https:\/\/doi.org\/10.1161\/circresaha.108.174367","journal-title":"Circ Res"},{"key":"4786_CR79","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jtcvs.2005.09.018","volume":"131","author":"R He","year":"2006","unstructured":"He R, Guo DC, Estrera AL et\u00a0al (2006) Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J\u00a0Thorac Cardiovasc Surg 131:671\u2013678","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4786_CR80","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jtcvs.2007.12.063","volume":"136","author":"R He","year":"2008","unstructured":"He R, Guo DC, Sun W et\u00a0al (2008) Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J\u00a0Thorac Cardiovasc Surg 136:922\u2013929","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4786_CR81","doi-asserted-by":"publisher","first-page":"e32963","DOI":"10.1371\/journal.pone.0032963","volume":"7","author":"T Radonic","year":"2012","unstructured":"Radonic T, De Witte P, Groenink M et\u00a0al (2012) Inflammation aggravates disease severity in Marfan syndrome patients. PLoS ONE 7:e32963. https:\/\/doi.org\/10.1371\/journal.pone.0032963","journal-title":"PLoS ONE"},{"key":"4786_CR82","doi-asserted-by":"publisher","first-page":"I371","DOI":"10.1161\/CIRCULATIONAHA.105.000927","volume":"114","author":"M Nataatmadja","year":"2006","unstructured":"Nataatmadja M, West J, West M (2006) Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. Circulation 114:I371\u2013377","journal-title":"Circulation"},{"key":"4786_CR83","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1161\/01.RES.84.6.695","volume":"84","author":"Y Han","year":"1999","unstructured":"Han Y, Runge MS, Brasier AR (1999) Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 84:695\u2013703","journal-title":"Circ Res"},{"key":"4786_CR84","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1083\/jcb.200611146","volume":"178","author":"S Lamouille","year":"2007","unstructured":"Lamouille S, Derynck R (2007) Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J\u00a0Cell Biol 178:437\u2013451","journal-title":"J Cell Biol"},{"key":"4786_CR85","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19:128\u2013139. https:\/\/doi.org\/10.1038\/cr.2008.328","journal-title":"Cell Res"},{"key":"4786_CR86","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1161\/01.RES.0000216405.85080.a6","volume":"98","author":"J Suzuki","year":"2006","unstructured":"Suzuki J, Jin ZG, Meoli DF et\u00a0al (2006) Cyclophilin A is secreted by a\u00a0vesicular pathway in vascular smooth muscle cells. Circ Res 98:811\u2013817","journal-title":"Circ Res"},{"key":"4786_CR87","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nm.1958","volume":"15","author":"K Satoh","year":"2009","unstructured":"Satoh K, Nigro P, Matoba T et al (2009) Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med 15:649\u2013656. https:\/\/doi.org\/10.1038\/nm.1958","journal-title":"Nat Med"},{"key":"4786_CR88","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/CIRCRESAHA.107.157776","volume":"101","author":"AWY Chung","year":"2007","unstructured":"Chung AWY, Au Yeung K, Sandor GGS et al (2007) Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Circ Res 101:512\u2013522","journal-title":"Circ Res"},{"key":"4786_CR89","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1177\/1535370215576312","volume":"240","author":"C Wang","year":"2015","unstructured":"Wang C, Qian X, Sun X et\u00a0al (2015) Angiotensin II increases matrix metalloproteinase 2 expression in human aortic smooth muscle cells via AT1R and ERK1\/2. Exp Biol Med 240:1564\u20131571. https:\/\/doi.org\/10.1177\/1535370215576312","journal-title":"Exp Biol Med"},{"key":"4786_CR90","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2006.12.016","volume":"252","author":"ES Kim","year":"2007","unstructured":"Kim ES, Sohn YW, Moon A (2007) TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells. Cancer Lett 252:147\u2013156","journal-title":"Cancer Lett"},{"key":"4786_CR91","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/sj.onc.1210046","volume":"26","author":"A Safina","year":"2007","unstructured":"Safina A, Vandette E, Bakin AV (2007) ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells. Oncogene 26:2407\u20132422","journal-title":"Oncogene"},{"key":"4786_CR92","doi-asserted-by":"publisher","first-page":"19327","DOI":"10.1074\/jbc.M314048200","volume":"279","author":"N Selvamurugan","year":"2004","unstructured":"Selvamurugan N, Kwok S, Alliston T et al (2004) Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2. J\u00a0Biol Chem 279:19327\u201319334","journal-title":"J Biol Chem"},{"issue":"181","key":"4786_CR93","doi-asserted-by":"publisher","first-page":"183ra158","DOI":"10.1126\/scitranslmed.3005025","volume":"5","author":"J Huang","year":"2013","unstructured":"Huang J, Yamashiro Y, Papke CL et al (2013) Angiotensin-converting enzyme-induced activation of local angiotensin signaling is required for ascending aortic aneurysms in fibulin-4-deficient mice. Sci Transl Med 5(181):183ra158. https:\/\/doi.org\/10.1126\/scitranslmed.3005025","journal-title":"Sci Transl Med"},{"key":"4786_CR94","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2006.10.013","volume":"194","author":"A Recinos 3rd","year":"2007","unstructured":"Recinos A 3rd, Lejeune WS, Sun H et al (2007) Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice. Atherosclerosis 194:125\u2013133","journal-title":"Atherosclerosis"},{"key":"4786_CR95","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1161\/01.ATV.0000143384.69170.2d","volume":"24","author":"M Ishibashi","year":"2004","unstructured":"Ishibashi M, Egashira K, Zhao Q et al (2004) Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 24:e174\u2013e178","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4786_CR96","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0008-6363(03)00523-6","volume":"59","author":"J Ejiri","year":"2003","unstructured":"Ejiri J, Inoue N, Tsukube T et\u00a0al (2003) Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker. Cardiovasc Res 59:988\u2013996","journal-title":"Cardiovasc Res"},{"key":"4786_CR97","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1161\/CIRCULATIONAHA.105.607168","volume":"114","author":"M Thomas","year":"2006","unstructured":"Thomas M, Gavrila D, Mccormick ML et al (2006) Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E\u2011deficient mice. Circulation 114:404\u2013413. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.607168","journal-title":"Circulation"},{"key":"4786_CR98","doi-asserted-by":"publisher","first-page":"C53","DOI":"10.1152\/ajpcell.2001.280.1.C53","volume":"280","author":"DA Siwik","year":"2001","unstructured":"Siwik DA, Pagano PJ, Colucci WS (2001) Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol, Cell Physiol 280:C53\u2013C60","journal-title":"Am. J. Physiol., Cell. Physiol."},{"key":"4786_CR99","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.athoracsur.2015.05.009","volume":"100","author":"NH Pope","year":"2015","unstructured":"Pope NH, Salmon M, Johnston WF et al (2015) Interleukin-6 receptor inhibition prevents descending thoracic aortic aneurysm formation. Ann Thorac Surg 100:1620\u20131626. https:\/\/doi.org\/10.1016\/j.athoracsur.2015.05.009","journal-title":"Ann Thorac Surg"},{"key":"4786_CR100","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1042\/CS20171529","volume":"132","author":"C Liu","year":"2018","unstructured":"Liu C, Zhang C, Jia L et al (2018) Interleukin-3 stimulates matrix metalloproteinase 12 production from macrophages promoting thoracic aortic aneurysm\/dissection. Clin Sci 132:655\u2013668. https:\/\/doi.org\/10.1042\/CS20171529","journal-title":"Clin Sci"},{"key":"4786_CR101","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1161\/CIRCULATIONAHA.113.006800","volume":"130","author":"WF Johnston","year":"2014","unstructured":"Johnston WF, Salmon M, Pope NH et al (2014) Inhibition of interleukin-1beta decreases aneurysm formation and progression in a\u00a0novel model of thoracic aortic aneurysms. Circulation 130:S51\u2013S59. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.006800","journal-title":"Circulation"},{"key":"4786_CR102","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejcts.2010.09.019","volume":"40","author":"L Zhang","year":"2011","unstructured":"Zhang L, Liao MF, Tian L et al (2011) Overexpression of interleukin-1beta and interferon-gamma in type I thoracic aortic dissections and ascending thoracic aortic aneurysms: Possible correlation with matrix metalloproteinase-9 expression and apoptosis of aortic media cells. Eur J Cardiothorac Surg 40:17\u201322. https:\/\/doi.org\/10.1016\/j.ejcts.2010.09.019","journal-title":"Eur J Cardiothorac Surg"},{"key":"4786_CR103","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivy256","author":"YF Jiang","year":"2018","unstructured":"Jiang YF, Guo LL, Zhang LW et al (2018) Local upregulation of interleukin-1 beta in aortic dissecting aneurysm: correlation with matrix metalloproteinase-2, 9 expression and biomechanical decrease. Interact Cardiovasc Thorac Surg. https:\/\/doi.org\/10.1093\/icvts\/ivy256","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"4786_CR104","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1182\/blood.V91.1.258","volume":"91","author":"P Biswas","year":"1998","unstructured":"Biswas P, Delfanti F, Bernasconi S et al (1998) Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 91:258\u2013265","journal-title":"Blood"},{"key":"4786_CR105","doi-asserted-by":"publisher","first-page":"e000476","DOI":"10.1161\/JAHA.113.000476","volume":"3","author":"X Ju","year":"2014","unstructured":"Ju X, Ijaz T, Sun H et al (2014) IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a\u00a0fibrillin-1 hypomorphic mgR\/mgR mouse model of severe Marfan syndrome. J\u00a0Am Heart Assoc 3:e476","journal-title":"J Am Heart Assoc"},{"key":"4786_CR106","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.nut.2012.02.006","volume":"28","author":"J Fan","year":"2012","unstructured":"Fan J, Li X, Yan YW et al (2012) Curcumin attenuates rat thoracic aortic aneurysm formation by inhibition of the c\u2011Jun N\u2011terminal kinase pathway and apoptosis. Nutrition 28:1068\u20131074. https:\/\/doi.org\/10.1016\/j.nut.2012.02.006","journal-title":"Nutrition"},{"key":"4786_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2018.05.246","author":"B Zhou","year":"2018","unstructured":"Zhou B, Li W, Zhao G et\u00a0al (2018) Rapamycin prevents thoracic aortic aneurysm and dissection in mice. J\u00a0Vasc Surg. https:\/\/doi.org\/10.1016\/j.jvs.2018.05.246","journal-title":"J Vasc Surg"},{"key":"4786_CR108","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.108.832972","volume":"119","author":"MB Pagano","year":"2009","unstructured":"Pagano MB, Zhou HF, Ennis TL et al (2009) Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm. Circulation 119:1805\u20131813. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.832972","journal-title":"Circulation"},{"key":"4786_CR109","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.4049\/jimmunol.1601386","volume":"200","author":"W Ren","year":"2018","unstructured":"Ren W, Liu Y, Wang X et al (2018) The complement C3a-C3aR axis promotes development of thoracic aortic dissection via regulation of MMP2 expression. J\u00a0Immunol 200:1829\u20131838. https:\/\/doi.org\/10.4049\/jimmunol.1601386","journal-title":"J Immunol"},{"key":"4786_CR110","doi-asserted-by":"publisher","first-page":"e107221","DOI":"10.1371\/journal.pone.0107221","volume":"9","author":"R Franken","year":"2014","unstructured":"Franken R, Hibender S, Den Hartog AW et al (2014) No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice. PLoS ONE 9:e107221. https:\/\/doi.org\/10.1371\/journal.pone.0107221","journal-title":"PLoS ONE"},{"key":"4786_CR111","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jtcvs.2013.02.073","volume":"146","author":"H Kurobe","year":"2013","unstructured":"Kurobe H, Matsuoka Y, Hirata Y et al (2013) Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects. J\u00a0Thorac Cardiovasc Surg 146:1501\u20131508. https:\/\/doi.org\/10.1016\/j.jtcvs.2013.02.073","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4786_CR112","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jvs.2007.09.016","volume":"47","author":"W Xiong","year":"2008","unstructured":"Xiong W, Knispel RA, Dietz HC et\u00a0al (2008) Doxycycline delays aneurysm rupture in a\u00a0mouse model of Marfan syndrome. J\u00a0Vasc Surg 47:166\u2013172","journal-title":"J Vasc Surg"},{"key":"4786_CR113","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jtcvs.2009.10.039","volume":"140","author":"HH Yang","year":"2010","unstructured":"Yang HH, Kim JM, Chum E et al (2010) Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome. J\u00a0Thorac Cardiovasc Surg 140:305\u2013312","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4786_CR114","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1749-6632.1999.tb07682.x","volume":"878","author":"RW Thompson","year":"1999","unstructured":"Thompson RW, Baxter BT (1999) MMP inhibition in abdominal aortic aneurysms. Rationale for a\u00a0prospective randomized clinical trial. Ann N Y Acad Sci 878:159\u2013178","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"4786_CR115","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1161\/CIRCULATIONAHA.108.806505","volume":"119","author":"JH Lindeman","year":"2009","unstructured":"Lindeman JH, Abdul-Hussien H, Van Bockel JH et al (2009) Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: Doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 119:2209\u20132216. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.806505","journal-title":"Circulation"},{"key":"4786_CR116","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2174\/157016111796197288","volume":"9","author":"BR Dodd","year":"2011","unstructured":"Dodd BR, Spence RA (2011) Doxycycline inhibition of abdominal aortic aneurysm growth: A\u00a0systematic review of the literature. Curr Vasc Pharmacol 9:471\u2013478","journal-title":"Curr Vasc Pharmacol"},{"key":"4786_CR117","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7326\/0003-4819-159-12-201312170-00007","volume":"159","author":"CA Meijer","year":"2013","unstructured":"Meijer CA, Stijnen T, Wasser MN et\u00a0al (2013) Doxycycline for stabilization of abdominal aortic aneurysms: A\u00a0randomized trial. Ann Intern Med 159:815\u2013823","journal-title":"Ann Intern Med"},{"key":"4786_CR118","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1046\/j.1365-2168.1999.01196.x","volume":"86","author":"GD Treharne","year":"1999","unstructured":"Treharne GD, Boyle JR, Goodall S et\u00a0al (1999) Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a\u00a0model of aneurysm disease. Br J Surg 86:1053\u20131058","journal-title":"Br J Surg"},{"key":"4786_CR119","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0741-5214(99)70354-X","volume":"29","author":"DA Bigatel","year":"1999","unstructured":"Bigatel DA, Elmore JR, Carey DJ et al (1999) The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J\u00a0Vasc Surg 29:130\u2013138","journal-title":"J Vasc Surg"},{"key":"4786_CR120","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","volume":"17","author":"A Winer","year":"2018","unstructured":"Winer A, Adams S, Mignatti P (2018) Matrix metalloproteinase inhibitors in cancer therapy: Turning past failures into future successes. Mol Cancer Ther 17:1147\u20131155. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0646","journal-title":"Mol Cancer Ther"},{"key":"4786_CR121","doi-asserted-by":"publisher","first-page":"6642","DOI":"10.1038\/sj.onc.1204097","volume":"19","author":"S Zucker","year":"2000","unstructured":"Zucker S, Cao J, Chen WT (2000) Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19:6642\u20136650","journal-title":"Oncogene"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-019-4786-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-019-4786-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-019-4786-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T19:22:57Z","timestamp":1662924177000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-019-4786-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":121,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4786"],"URL":"https:\/\/doi.org\/10.1007\/s00059-019-4786-7","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,12]]},"assertion":[{"value":"12 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"N.E.H.\u00a0Dinesh and D.P.\u00a0Reinhardt declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}